HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Performance of a 99mTc-labelled 1-thio-beta-D-glucose 2,3,4,6-tetra-acetate analogue in the detection of infections and tumours in mice: a comparison with [18F]FDG.

AbstractOBJECTIVE:
The aim of this study was to investigate the differences in biological performance between a technetium-99m (Tc)-labelled glucose derivative, the Tc-labelled 1-thio-beta-D-glucose 2,3,4,6-tetra-acetate analogue (Tc-TG) with F-fluoro-2-deoxy-glucose ([F]FDG).
METHODS:
Binding of both tracers was performed in vitro to viable tumour cells and bacteria. Both tracers were injected into mice for targeting Staphylococcus aureus thigh muscle infections and subcutaneous rat lymphoma (RMA) tumours by using scintigraphy, or by radioactivity counts in excised tissues to determine the biodistribution.
RESULTS:
In-vitro binding studies revealed that both tracers bind more effectively to tumour cells expressing the glucose transporter 1 rather than the glucose transporter 2, and this binding was specific for [F]FDG. Tc-TG shows the highest binding to bacteria and, in addition, gives the highest rate of accumulation in infected thigh muscles in mice. Both tracers were rapidly removed from the circulatory system through the kidneys, and the majority of the injected radioactivity accumulated in the urinary bladder. Two hours after the injection radioactivity accumulation in two high-energy-dependent organs, heart, and liver, increased. Within 15 min of the injections, Tc-TG visualized the site of S. aureus infection or the tumour.
CONCLUSION:
We conclude that the new tracer Tc-TG may have potential use as a SPECT agent for infection and tumour imaging.
AuthorsMick M Welling, Roger Alberto
JournalNuclear medicine communications (Nucl Med Commun) Vol. 31 Issue 3 Pg. 239-48 (Mar 2010) ISSN: 1473-5628 [Electronic] England
PMID20032803 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Acetates
  • Glucose Transporter Type 1
  • Organotechnetium Compounds
  • Radiopharmaceuticals
  • Slc2a1 protein, rat
  • Thioglucosides
  • technetium 99m 1-thioglucose 2,3,4,6-tetraacetate
  • Fluorodeoxyglucose F18
  • Technetium
  • Glucose
Topics
  • Acetates (chemistry)
  • Animals
  • Cell Line, Tumor
  • Fluorodeoxyglucose F18 (pharmacology)
  • Glucose (metabolism)
  • Glucose Transporter Type 1 (metabolism)
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neoplasms (diagnosis, diagnostic imaging)
  • Organotechnetium Compounds (pharmacology)
  • Radionuclide Imaging
  • Radiopharmaceuticals (pharmacology)
  • Rats
  • Staphylococcus aureus (metabolism)
  • Technetium (pharmacology)
  • Thioglucosides (pharmacology)
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: